Ozempic, Xtandi Among Next 15 Drugs Selected for U.S. Price Talks
Saturday, Jan 18, 2025 8:34 am ET
1min read The Biden administration has announced the next 15 drugs to be included in Medicare's price negotiation program, a move that could significantly impact the pharmaceutical industry and drug prices for seniors. Among the selected drugs are popular weight loss medications like Ozempic and Wegovy, as well as blockbuster cancer medications and other drugs that account for a third of prescription drug spending in Medicare Part D. The negotiations are set to take effect in 2027, with drugmakers having until February 28 to decide whether to participate or face a hefty tax if they want to stay covered by Medicare and Medicaid.
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
_183e5bc31749756677125.jpeg)
